PFSAProfusa, Inc. · Nasdaq Capital Market · $2.05 · $1.63M mkt cap
Assessed Sep 17, 2026 · 8-K financing event
Is the float you're seeing correct?
518.8K
Estimated float

Cover-page shares outstanding (8/18/26, post all three reverse splits) minus the DEF 14A insider group total, which already reflects the 8/21 NorthView distribution.

Confirmed · within 1%
518.8K
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener's float is right for PFSA. Trade off 518.8K shares. What it does not show you is what is about to be added to it.

Dilution risk9/10EXTREME
CONFIDENCE: MEDIUM

The float your screener shows is right, at 518.8K. An active $86.9M ATM, 1 floorless convertible note and 3 reverse splits can add another 3,662% of the float.

  • Preferred stock conversion overhang. 61,212 Series A Non-Voting Preferred convert into 15,053,062 common, about 29x the float and 25x shares outstanding.

  • Variable-rate convertible notes (death spiral). About $6.1M of Ascent PIPE notes convert at the lower of the fixed price or 95% of the lowest 10-day VWAP.

  • ELOC draws and remaining capacity. $86.9M remains on the Ascent ELOC, 80x the $1.08M market cap, priced at 97% of the lowest 10-day VWAP.

From today's float to the ceiling

shares
518.8K
Estimated float
tradeable today
+267.1K can sell now
785.9K
Effective supply
float plus what sells on notice
+32.21M if floors are cut and warrants exercise
33.00M
Fully diluted
ceiling

Ceiling computed from the itemised overhang.

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
518.8K
Can sell now
Registered resale shares, issuable on notice
Already effective; the holder can sell without a further filing.
+233.6K
Warrants in the money
Exercisable at or below the current tape.
+33.5K
Effective supply
785.9K
Converts only if floors are cut · floors $4.28 to $14400.00 against a $2.05 tape
Convertible notes, beyond the registered shares
At the stated conversion prices; a cut to those prices raises the count.
+3.68M
Preferred stock, as converted
Common equivalent at the stated conversion ratio.
+28.53M
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+2.3K
Options and RSUs
Employee equity; vests and settles over time.
+245
Fully diluted
33.00M

ATM program active with $86.9M of registered capacity remaining. Public float is under $75M, so the baby-shelf rule caps primary sales near $355K per 12 months; the headline figure is not the near-term supply.

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

Engine fully-diluted count (19.60M) is below the itemised overhang; ceiling computed from the rows.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
$2.05
Market cap
$1.63M
Shares outstanding
605.6K
Reported float
518.8K
Avg volume
861.2K
Reverse splits
3 · latest 1-for-4 · Aug 17, 2026
Going concern
Yes · 0 quarters runway
Quarterly burn

Market data as of Sep 24, 2026

Key dates

  • Sep 18, 2026 · Stockholder meeting on a fourth reverse split (1:2 to 1:12) to defend the Nasdaq $1.00 bid
  • Sep 30, 2026 · Bio Insights $30M preferred deal becomes terminable if not closed
  • Dec 31, 2026 · NorthView note ($577K) matures; convert-or-repay decision
  • Jan 1, 2027 · Share-settled monthly amortization begins on the 9/1 and 9/16 Ascent notes